Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Press Releases
RioCan Real Estate Investment Trust Announces Agreement With Cedar Shopping Centers, Inc. For an Equity Investment and Real Estate Joint Venture in the Northeast United States
RidgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on DWA, FMC, HW, VR, GAP and KRC
NCI Five Dose Study of PharmaGap Lead Drug Underway
Investment Industry Regulatory Organization of Canada - Trade Resumption - PharmaGap Inc. - GAP
Investment Industry Regulatory Organization of Canada - Trading Halt - Pharmagap Inc. - GAP - V
Investment Industry Regulatory Organization of Canada - Trading Halt - Pharmagap Inc. - GAP
The Great Atlantic and Pacific Tea Co. Completes $435MM Capital Raising Effort
The Great Atlantic & Pacific Tea Company, Inc. Announces Pricing of $260 Million 11.375% Senior Secured Notes due 2015
The Great Atlantic & Pacific Tea Company, Inc. Announces Major Investment Agreements
The Great Atlantic & Pacific Tea Company, Inc. Announces Proposed Offering of $225 Million of Senior Secured Notes due 2015
PharmaGap Provides Guidance on Cancer Drug Testing Timetable
PharmaGap Raises Additional Equity Financing
BenchmarkJournal.Com Free Analyst Review for GAP, ATU, PPHM, MNKD, HLIT and COCO
PharmaGap Announces Agreement for the Issuance of Shares to National Research Council of Canada
The Great Atlantic & Pacific Tea Company, Inc. Announces Results for Its Fourth Quarter and Full Year Ended February 28, 2009
PharmaGap Finalizes Conversion of Convertible Debentures
PharmaGap Announces Option Grants to Officers and Directors
The Great Atlantic & Pacific Tea Company, Inc. Announces Results for Its Third Quarter Ended November 29, 2008
The Great Atlantic & Pacific Tea Company, Inc. Announces Results for Its Second Quarter Ended September 6, 2008
The Great Atlantic & Pacific Tea Company, Inc. Announcement
A&P Establishes Hurricane Preparedness Guide
The Great Atlantic & Pacific Tea Company's Live Better! Wellness Program Now Provides Full Pharmacy Benefits Management (PBM) Services
A&P Executive to Speak at Goldman Sachs' Conference
PharmaGap Closes $1.1 million Public Portion of Anticipated $2.6 million Equity Financing; Announces Full Clinical Development Group to Take Lead Cancer Drug into Human Clinical Trials
PharmaGap Files Final Prospectus for Issue of Equity Units and announces $1,555,395 Private Placement to SC Stormont Holdings
The Great Atlantic & Pacific Tea Company, Inc. Announces Results for Its First Quarter Ended June 14, 2008
The Great Atlantic & Pacific Tea Company Takes Price Impact's Pathmark Sav-A-Center to Philadelphia
The Great Atlantic & Pacific Tea Company, Inc. Provides Comparable Prior Year Pathmark Data
PharmaGap to raise approximately $4.5 million in public offering of equity securities
PharmaGap establishes clinical development group to take drug to clinical trials
The Great Atlantic & Pacific Tea Company, Inc. Announces Cash Settlement of Series A Warrants
PharmaGap animal tests show 34% reduction in tumour size and increased survival in solid tumour tests of two colon cancer cell lines
The Great Atlantic & Pacific Tea Company, Inc. Announces Results for Its Fourth Quarter and Fiscal Year Ended February 23, 2008 - Jun 3 2008 3:13AM
A&P Executive to Speak at Lehman Brothers' Conference
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia